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The lack of a  susceptible animal and of an in vitro system for the propagation of 
the causative agent of viral hepatitis have hindered our full understanding of this dis- 
ease.  The use of human volunteers as the only susceptible experimental subjects has 
given valuable information but such experiments have been necessarily very limited. 
Many nonprimate animal species have been evaluated repeatedly for susceptibility 
to human viral hepatitis but with negative results. Nonhuman primates were claimed 
several times to be susceptible, but a review by Evans in 1954 (1) stated that none of 
these  studies  had  established that  the  disease could  be  transmitted  to  nonhuman 
primates. Studies on chimpanzees in the Belgian Congo in  1958  (2) again gave only 
suggestive evidence of transmission of human viral hepatitis. In contrast to the failures 
of  transmission from  man  to primates,  evidence has  recently accumulated for  the 
transmission of  a  disease,  indistinguishable from  human  viral hepatitis, from  non- 
human  primates to  man  (3).  Such primate-associated human  cases may,  however, 
result from several mechanisms. They may represent an original transmission from 
man to nonhuman primates. Multiplication and excretion of the agent by the primate 
may then occur with subsequent reinfection of man. Or, man may occasionally  become 
infected with a  nonhuman  primate hepatitis agent different from  that agent which 
ordinarily causes human  viral hepatitis. These  observations have  stimulated inves- 
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tigators to search again for a  nonhuman  primate  susceptible  to the elusive agent or 
agents of human viral hepatitis (4, 5). 
For the past 5 yr we have studied small South American nonhuman primates 
(marmosets)  for their possible use as laboratory animals. In attempts  to estab- 
lish their susceptibility  to various human  infections,  we have inoculated  these 
animals with materials from patients  suffering from viral hepatitis.  The results 
of these studies  are reported here. 
Materials and Methods 
Marmosets.--Most  of the marmosets  used  in  this  study  were white lipped,  hairy  faced 
tamafins (Saguinus fuscicollis  and Saguinus  nigrieoUis) but some crested,  barefaced,  cotton 
top tamarins  (Saguinus  (Oedipus) oedipomidas) were used in initial studies.  No differences 
were observed in the responses of the two types of animals. 
TABLE I 
Normal  Values of Certain Hepatic Tests in Randomly  Selected, Wild-Caught Marmosets 
Test 
Glutamic oxalacetic transaminase  (units) 
Isocitric dehydrogenase (units) 
Bilirubin, direct 
Bilirubin, indirect 
Mean 
105 
715 
0.10 
0.10 
Range 
48-204 
274-1466 
0.0-0.3 
0.0-0.4 
N* 
125 
122 
128 
128 
* N, number of determinations on which these figures are based. 
Handling  of Animals.--The  general husbandry,  experimental procedures,  and  establish- 
ment of biological baseline values for marmosets in our colony have been described previously 
(6-8). All animals were wild caught and were used in these studies after at least 6 wk in the 
laboratory, after three consecutive sets of serum enzyme determinations (see below) and after 
at least one liver biopsy. Only animals with normal enzyme levels and normal liver histology 
(see section on pathology) were selected for individual experiments. Control and inoculated 
animals were housed, fed, and handled under identical conditions. Two to four animals of the 
same experimental group were caged together but the groups were removed as far as possible 
from each other.  Complete isolation was unfortunately  impossible in our facilities but  the 
position of cage batteries in different corners of the same room, or whenever possible in differ- 
ent rooms, reduced the possibility of transmission between groups to a minimum. Anesthesia 
was not necessary for bleeding or biopsy. The animals received no medication except for molyb- 
denized ferrous sulfate suspension  added to the drinking water of animals bled more than once 
a week. In addition all animals received a pediatric multiple vitamin preparation in syrup in 
their drinking water. 
Biochemical Hepatic Tests.--Serum activity of glutamic oxalacetic transaminase  (SGOT) 
was measured by the method of Karmen, Wroblewski, and LaDue (9), that of serum isocitric 
dehydrogenase  (SICD)  by the method  of Wolfson and  Williams-Ashman  (10),  and  serum 
bilirubin by the method of Evelyn and Malloy (11). Normal values in randomly selected wild- 
caught adult marmosets of our colony are shown in Table I. 
Liver Biopsies.--Liver tissue was obtained with a  40  X  1.40 mm Menghini needle using 
the two man technique (12). The tissue was fixed in 10% formalin buffered with phosphates ~F.  DEINHARDT,  A.  W.  HOLMES,  R.  B.  CAPPS,  AND  H.  POPPER  675 
to pH  7.4, sectioned, and stained as routine with hematoxylin and eosin or in periodic acid- 
Schiff (PAS) reagent before and after diastase digestion of glycogen. Selected sections were 
subjected to iron stain, connective tissue stains, and silver impregnation. 
Cell Cultures.--The preparation  and  maintenance of  primary  newborn human  kidney, 
adult marmoset kidney, and diploid human embryonic fibroblast cultures have been described 
elsewhere (13). 
Inoculat4ons.--Inocula were diluted 1: 2 in Hanks' balanced salt solution and a 0.5 ml total 
volume was inoculated per animal. In early experiments material was injected into a tail vein 
but femoral vein inoculation was used in later groups. 
Testing of Inocula.--All materials used for inoculation of marmosets were inoculated before 
use into standard bacteriological and mycoplasma media and into newborn human and/or 
adult marmoset kidney cell cultures. The inoculated cell cultures were incubated in a station- 
ary manner for 7 days and three blind passages were performed by transferring frozen and 
thawed medium and cells from the previous passage. The cultures were observed for the devel- 
opment of cytopathie effect and, in addition, the cultures of the third passage were tested for 
hemadsorption with chicken, guinea pig, and human type O erythrocytes and for interference 
by superinfection with vesicular stomatitis virus (14). None of these tests indicated the pres- 
ence of infectious agents. 
Experimental Design 
Mter selection for individual experiments, animals were randomly distributed into experi- 
mental and control groups. After inoculation the animals were observed for signs of overt 
disease and were bled by venipnneture at least once a week. SGOT and SICD activities were 
measured in each serum sample. If they were elevated, direct-reacting and total serum bilirubin 
were also determined. SCOT values of 200 units and SICD values of 2000 units were taken 
as the upper limits of normal. Normal bilirubin values in marmosets, as in other nonhuman 
primates, are lower than in man, and values above 0.15 rag per 100 ml direct-reacting serum 
bilirubin and above 0.50 mg per 100 ml total serum bilirubin were considered significantly 
elevated. Needle biopsies were performed every 2 wk and, in most instances, also on the day 
the hepatic tests yielded abnormal  values  for  the  first time.  The  biopsies were  coded  and 
evaluated under code. 
Stool samples were collected from some control and inoculated animals of the experimental 
groups twice weekly for virus isolation. The specimens were coded,  stored at  --65°C.,  and 
evaluated under code in various tissue cultures. 
RESULTS 
Six attempts  were made  to induce hepatitis in marmosets  by inoculation of 
human  serums  or  plasmas.  In  five  instances  the material  had  been  obtMned 
from patients  with hepatitis, in the sixth the inoculum had been shown not to 
cause hepatitis in human  volunteers. Each attempt  represents a  group of experi- 
ments  and will be discussed separately. 
Group 1.-- 
D. M., an 18-yr-old student nurse in an institution where infectious hepatitis is endemic 
(15), developed malaise and anorexia with hepatic tests indicative of hepatitis. She was sick 
for about 6 wk, with jaundice for 2 wk. Liver function 8 wk after the onset of symptoms was 
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Serum  obtained  on  the  second day  of jaundice  was  inoculated  into  three 
marmosets. Only one animal developed enzyme elevations 80 days after inocula- 
tion  (SGOT  276,  SICD  4750)  without  histological  changes  in  liver  biopsy. 
Serum enzymes were elevated for 2 wk and were again normal for the subse- 
quent 5 wk. Serum from the one questionably positive animal, obtained at the 
time of the enzyme elevations,  was  injected  into  four  more  marmosets  in a 
subsequent experiment.  One of these animals had only slight SGOT elevations 
77 and 84 days later (212 and 284, respectively) and the other three remained 
normal throughout the 4 months of observation.  Liver biopsy specimens were 
again normal in all animals.  A  third passage in four more marmosets was at- 
tempted with serum from the second passage animal, which had had borderline 
elevation  of  enzyme  activity,  but  no  chemical  or  histological  abnormalities 
were observed over a period of 12 wk. 
Group 2.-- 
G.  B.,  a  34-year-old surgeon, developed acute  hepatitis,  lie had not knowingly exposed 
himself to serum hepatitis. He was moderately ill and acute phase serum was obtained on the 
third day of jaundice during an illness characterized  by a maximum total serum bilirubin of 
14.4 mg per 100 ml and icterus of 4 wk duration. 
The  acute  phase  serum  was  inoculated  into  four marmosets,  all  of which 
developed abnormal hepatic tests  16-40 days later,  liver biopsies also showing 
definite abnormalities.  Serum obtained from one of the animals on the day that 
elevated serum enzyme activities were first observed was inoculated into a new 
group  of  four  marmosets.  Five  serial  marmoset-to-marmoset  passages  were 
carried  out with almost  all inoculated animals  showing chemical evidence of 
disease (Text-fig. 1) with peak SGOT activities from 400 to 900 units and SICD 
activities  as high as 12,000 units.  Many animals had hyperbilirubinemla,  and 
incubation periods varied but tended to cluster around 20 days, particularly in 
the later passages. 
Group 3.-- 
B. B., was 36-year-old man who entered the hospital because of anorexia for more than a 
week, and jaundice allegedly for only 24-hr. He was deeply icteric and had a total serum biliru- 
bin of 35 mg per 100 ml on the day following admission. He died 5 days later in hepatic coma. 
Serum taken on the second hospital day, when the total serum bilirubin had 
risen to 54 mg per 100 ml, was inoculated into five marmosets and these animals 
showed no chemical abnormalities during the next 4 months. 
Group 4.-- 
A 9-year-old girl, M. J., entered the hospital with anorexia and nausea for a week and a 
history  of exposure to hepatitis.  Her hepatic  tests  suggested anicteric  hepatitis  (cephalin 
flocculation 3+, SCOT 240, serum glntamic  pyruvic transaminase  275, bilirubin  0.10 mg 1~.  DEINHARDT,  A.  W.  HOLMES,  R.  B.  CAPPS,  AND  H.  POPPER  677 
direct-reacting, and 0.75  nag per 100 ml total). She never became jaundiced and hepatic tests 
were normal 2 wk later. Serum was obtained on the 8th day of her disease. 
Serum from M.  J. was inoculated into five marmosets and they showed no 
evidence of hepatitis over the next 4 months. 
TgxT-Fxo. 1. Serial passages in group 2. Each row of blocks represents a single experiment, 
each block represents  a  single animal.  Animals which showed no evidence of liver disease 
throughout the experiment are shown by shaded blocks.  ~nirnals with biochemical-evidence 
of hepatitis are shown by open blocks,  and the number inside the block is the number of days 
from inoculation to first abnormal hepatic tests. The vertical arrows originate from the blocks 
representing animais from which serum for passage was obtained. The asterisks indicate hy- 
perbilirubinemia.  (Bilirubin  determinations were not done  in  experiment  2-6  because  the 
available serum was used in other studies.) 
Group 5.-- 
Through the courtesy of Drs. I. W. McLean and Wilton Rightsel of Parke, Davis and Co., 
Detroit, Mich., aliquots of the original WW-55  plasma and a  control plasma were received 
under  a  code which was  broken only after the completion of the experiment. The WW-55 
plasma had induced hepatitis in about 50% of human  volunteers with an incubation period 
of about 35 days (16). The control plasma, on the other hand, had been shown to be nonictero- 
genic for man. 
Both plasmas were inoculated at the same time into two groups of nine mar- 
mosets each. The subsequent course of the animals receiving control material 
is described under group 6. Six of the nine animals which were inoculated with 
WW-55  plasma  developed  biochemical  evidence  of  hepatitis  in  35-91 
days (Text-fig. 2). Needle biopsies showed abnormalities consistent with viral 678  HEPATITIS  IN  MARMOSETS.  I 
hepatitis.  In  two  subsequent  marmoset-to-marmoset passages,  using  acute 
phase marmoset sera  as  in  the  earlier  attempts,  10  of  14 inoculated  animals 
developed  chemical  and  histological  liver  disease  with  incubation  periods  of 
16-90 days. 
Group 6.-- 
This group of experiments consisted of the inoculation and passage of the control plasma 
referred to in group 5. This plasma had been inoculated into human volunteers without causing 
any disease (16). 
TEXT-FIG. 2. Serial passages in group 5. The explanation of this figure is the same as for 
Text-fig. 1. 
The  control plasma was injected into  nine marmosets which did  not,  over 
the next 5 months, show any evidence of chemical or histological liver disease. 
Serum harvested from two of these animals 40 days after inoculation,  at the 
same time as the serum for passage was obtained from the animals in group 5, 
was administered to another group of eight marmosets.  These animals did not 
develop liver disease during the following 5 months. Serums from all animals of 
this second passage were obtained on the 35th  day after inoculation,  pooled, 
and inoculated into a  third group of 4  marmosets which remained chemically 
and histologically normal for the succeeding 4 months. 
Other Inoculations.--We  also inoculated a  preparation of adenovirus type 5 
intramuscularly. This agent was isolated by Dr. W. D. Hillis from a  chimpan- 
zee involved in  an outbreak of chimpanzee-associated hepatitis  (17).  No  ab- 
normalities were observed in these animals during 4 months. 
A serum from a patient with typical infectious mononucleosis was inoculated 
intravenously into five animals. None showed  heterophile antibodies,  atypical 
lymphocytosis, serum enzyme rises, or changes of liver biopsy during 4 months. i  ~. DEINHARDT,  A. W. HOLMES, R. B. CAPPS, AND  H. POPPER  679 
General and Biochemical Data.--None of the animals with abnormal hepatic 
tests and/or with histological evidence of liver damage exhibited any signs of 
overt illness.  Serum enzyme activities (SGOT and SICD) rose in animals from 
three of the five groups inoculated with potentially positive material  but  the 
curves of successive serum enzyme values were not the same from animal to 
animal. Some marmosets had a single "spike" of rather short duration (Text-fig. 
3);  others  had a  biphasic  curve with two periods of illness  (Text-fig.  4)  with 
either  the first or the second enzyme elevation higher and longer.  Others  re- 
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"~xT-Fxo. 3.* Course of biochemical abnormalities in a single marmoset from experiment 
2-4. Note the single "spike"of elevated SGOT and SICD activities over a period of 3 wk. 
sponded with persistent biochemical abnormalities for many weeks (Text-fig. 5). 
Serum levels over 0.15 mg per 100 ml direct-reacting bilirubin and 0.50 mg per 
100 ml of total bilirubin occurred in 9 of 21 infected animals in group 2 and in 
3 of 16 animals in group 5. 
Animals of the last passage of group 2 are not included in this count as no bilirubin deter- 
minations were performed because all available serum was used for determining various other 
enzyme levels which will be reported in detail elsewhere.  1 
* Reprinted  by permission from: Deinhaxdt, F.,  and A. W. Holmes. 1965. Epidemiology 
and etiology of viral hepatitis. In Progress in Liver Diseases. Hans Popper and Fenton Schaff- 
ner, editors. Grune and Stratton, New York and London. 2:380. 
1 Mohr, J., and H. Mattenheimer.  Unpublished observations. 680  HEPATITIS  IN  MARMOSETS.  I 
The isoenzymes of lactic dehydrogenase were determined by electrophoretic 
separation in six  serums each from control  and infected animals during the 
acute stage of their disease. During acute liver injury (acute stage serums) the 
fastest moving isoenzyme (which is predominantly present in liver tissue) was 
increased both in absolute amount and in percentage of total lactic dehydro- 
genase activity (Table II).  1 
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The evaluation of stool samples from control and inoculated animals is not 
yet completed but, except for some known enteric viruses recovered from both 
control and inoculated animals, no agents have been detected which could be 
linked to the inoculations. 
Histopatkologic Findings.--The livers of randomly selected untreated control 
marmosets or marmosets inoculated with control materials revealed,  in  the 
studied biopsy specimens, liver cells varying in size and usually containing much 
glycogen. This increased glycogen content was indicated in hematoxylin eosin 
sections by fine vacuolated and granulated cytoplasm (Fig.  1 a). The nuclei 
appeared vesicular but often dense and the nucleoli were not always conspicu- 
ous. The chromatin was accentuated on the nuclear membrane but was other- 
wise fairly homogeneous. Binucleated cells  were frequent. Brown argentaffin 
pigment granules without iron reaction, seemingly lipofuscin, were seen around 
the bile canaliculi and, in effect, outlined them (Fig. 1 b). Sinusoidal ceils were F. DE~HA-~T,  A. W. HOT.I~I~S,  R. B. CAPPS, AND H. POPPER  681 
moderately prominent, but contained little PAS-positive nonglycogenic mater- 
ial. The walls of the central veins were thin and their lining endothelial cells 
flat (Fig.  1 c).  Occasionally, mononuclear inflammatory cells accumulated in 
sinusoids (Fig. 1 d), and very exceptionally they replaced liver cells to produce 
small focal necroses.  The sinusoidal walls were fairly prominent and gave a 
distinct reaction in aniline blue connective tissue stains as well as with PAS. 
In silver impregnation, the reticulum framework lined the sinusoids. The portal 
tracts were, as a  rule, poor in cells  (Fig. 1 a),  but in very few instances they 
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T~,xT-FIG. 5.  SGOT and SICD  levels in a  marmoset from experiment 2-1. Note the  pro- 
tracted period during which elevated enzyme activity was found in the serum of this animal. 
contained inflammatory cells, either of histiocytic character with PAS-positive 
cytoplasm or lymphocytes, but only rarely were segmented leukocytes and 
plasma cells noted (Fig. 1 e). Proliferation of bile ductules was not conspicuous. 
In some specimens, microfilariae were seen in sinusoids. 
The specimens from many inoculated animals exhibited changes which were 
not found in controls, and some alterations found in controls were accentuated. 
Alterations in inoculated animals, observed during the week before the first 
enzyme elevations were noted, included increase in the number and activation 
of sinusoidal cells (Fig. 2 b) with conspicuous focal necroses and portal inflam- 
marion with bile duct proliferation (Fig. 2 a). 
At the height of the enzyme elevations the most conspicuous findings were 682  HEPATITIS IN MARMOSETS. I 
alterations of the hepatocytes which differed from those in control specimens in 
that the cells varied in staining qualities of cytoplasm and of nuclei,  even with 
considerable variation between neighboring cells (Fig. 2 c). In hematoxylin and 
eosin sections, scattered dark cells were seen (Fig. 2 d). Moreover, some hepato- 
cytes  appeared  either  denser  in  toto  or a  portion  of the  cytoplasm  exhibited 
greater density giving the character of eosinophilic homogenization  (Figs.  2 d, 
3  a). In PAS stains without  diastase  digestion,  these dense portions appeared 
free of glycogen. Moreover, in these stains the variation in neighboring cells was 
particularly well brought out since they reflected inequalities  in glycogen con- 
TABLE II 
Activity  of Lactic  Dehydrogenase and  Its Isoenzymes  in Serum from  Normal Marmosets, 
Marmosets  with  Histological  and  Bioekemical  Evidence  of Hepatitis,  and  in  Normal 
Marmoset Liver  Tissue 
Test samples 
Normal marmoset 
serum 
"Hepatitic" mar- 
moset serum 
Normal marmoset 
liver tissue 
Activity* ......... 
% of total ac- 
tivity .......... 
Activity* ......... 
% of total activ- 
ity ............. 
Activity:~ ......... 
% of total activ-.. 
ity ............ 
1 
64.9 
44.3 
262. I 
23.4 
0 
0 
LDH  -Isoenzyme 
2  3  4  5 
.~4.6  16.8  18.6  21.5 
[6.8111.5112.7  14.7 
658 
s9  545 
0  0  21.6  4~8.4 
0  0  4.6  95.4 
LDH 
total 
146.4 
1115.4 
470.0 
Note the predominance  of isoenzyme  in whole liver  tissue  and the absolute and pro- 
portional elevation of this isoenzyme in serum from marmosets with acute hepatitis. 
* International units/liter. 
~: International units/100 g wet weight. 
tent in neighboring cells (Fig. 3 b). In addition,  some enlarged hepatocytes had 
a glycogen poor, very light cytoplasm giving a ballooned appearance (Fig. 3 c). 
The nuclei varied in size.  Many were more vesicular  than were those of con- 
trois, and their chromatin appeared irregularly arranged and peculiarly clumped 
(Fig.  3 f). This resulted in a  coarse stippling of the nuclei and irregularly out- 
lined  unstained  zones  (Fig.  3  d).  Occasionally  nuclei  were  ballooned.  Focal 
necroses  were  numerous  and  mainly mononuclear  cells,  either  histiocytes  or 
lymphocytes, replaced liver cells (Figs. 3 a, 3 f). Some foci of necrosis were ex- 
tensive, resulting in large accumulations of inflammatory cells. Another feature, 
only found in hepatitis, was inflammation of the central veins. Their walls were 
thickened  and  contained  inflammatory  cells of various  characteristics.  More- 
over, their lining cells were proliferated and bulged into the lumen (Fig.  3 e). 1~.  DEINHARDT,  A.  W.  HOLMES,  R.  B.  CAPPS,  AND  H.  POPPER  683 
The changes found occasionally in controls and markedly accentuated in 
hepatitis included accumulation of inflammatory cells both in the parenchyma 
and in the portal tracts. In the parenchyma, the sinusoidal cells appeared far 
more numerous and a much larger number contained PAS-posifive nonglyco- 
genic material. They accumulated sometimes in small clusters in dilated sinu- 
soids (Fig. 4 a). The portal tract inflammation was far more severe and more 
uniform, sparing no portal tract. The same type of inflammatory cells accumu- 
lated with occasional admixture of segmented leukocytes. Sometimes bile duct- 
ules had proliferated (Fig. 4 b). In one marmoset (group 5, third passage) the 
alterations were more conspicuous than in all others, both in the parenchyma 
and in the portal tracts (Fig. 4 c). The number of focal necroses was considera- 
bly greater and the alteration of the hepatocytes involving both nuclei and 
cytoplasm was much accentuated. Eosinophilic homogenous cells with pyknotic 
nuclei were seen, although it was not clear whether they were of hepatocytic or 
Kupffer cell origin (Fig. 4 d). Even in small portal tracts, the accumulation of 
inflammatory cells was impressive and plasma cells were fairly frequent (Fig. 4 
e).  This animal had had elevated enzyme activities since the 23rd day after 
inoculation (SGOT up to 226 units and SICD up to 8042 units) and died on the 
30th day. The SGOT and SICD activities on the day of death were 216 and 
4510  units respectively. The marmoset was not clinically ill and death was 
caused by a tension pneumothorax following liver biopsy. 
The morphological alterations persisted in a  number of animals for several 
weeks after the date the serum enzyme activities had returned to normal. These 
alterations include disarray of the liver cell plates with variation in the appear- 
ance of neighboring hepatocytes, few focal necroses, and considerable prolifera- 
tion of sinusoidal cells  (Fig.  5  a).  Similarly, the portal  tracts remained en- 
larged and  densely infiltrated in some instances  while the  hepatocytes still 
showed severe alteration;  even phlebitis of the hepatic vein tributaries  was 
noted (Fig. 5 b). Borderline alterations such as conspicuous focal excess of sinus- 
oidal cells and variations of liver cell size were also noted in some marmosets 
that had not developed any rises in serum enzyme activities after injection with 
inocula which, however, had induced chemical liver disease in other animals 
(see results under groups 2 and 5) (Fig. 5 c). In serial biopsies, hepatic changes 
such as disarray of hepatocytes with focal necrosis and inflammatory reaction 
preceded the enzyme rise (Fig. 6 a), and the full-blown picture of hepatitis was 
still seen when the enzyme activities were returning to normal levels (Fig. 6 b). 
Even 2 wk later, while the enzyme activities had remained normal, definite 
hepatic alterations and particularly focal necrosis were still seen (Figs., 6 c, 6 d). 
DISCUSSION 
Past experiences have shown that it is necessary to evaluate any apparent 
transmission of human viral hepatitis to experimental animals with particular 
caution. A  suitably wary approach may be found in a reformulation of Koch's 684  HEPATITIS IN  MARMOSETS.  I 
postulates.  Can  the causative agent be isolated regularly from patients suf- 
fering from hepatitis?  Can  the agent be passed  serially from one animal  to 
another by materials  free of other microorganisms? Does the agent produce 
in inoculated animals a disease identical with or similar to the disease in man? 
Can a rise in antibodies to the agent be demonstrated both in man and in the 
experimentally infected animals? Can the morphology, and the chemical, physi- 
cal, and antigenic characteristics of the agent be determined? And after several 
animal passages does the agent still induce the same disease if reinoculated into 
man? 
The inoculation of acute serums or plasmas from human cases of viral hepati- 
tis into marmosets induced definite biochemical and morphological hepatitis 
in two out of five attempts.  Of the three failures one gave borderline results 
and two were totally negative (these two materials were theoretically less likely 
to contain virus). Inoculations of a control human serum, an acute phase serum 
from a case of infectious mononucleosis, and an adenovirus type 5 preparation 
did not induce pathological changes in marmosets. These results are similar to 
the frequency of virus isolations in other known virus diseases. 
Hepatic  disease  was  produced  regularly  in  serial  marmoset-to-marmoset 
passages by transfer of acute marmoset serums. The incubation periods varied 
considerably in the early passages but became less  variable and shorter after 
two or more animal passages with a simultaneous increase in the severity of the 
disease. This apparent adaptation of an agent to a new host is observed in many 
instances when viruses are transferred from one animal species to another. The 
disease induced in marmosets was  probably  caused  by  a  microorganism, as 
a  toxic factor would be unlikely to persist through six animal-to-animal pas- 
sages.  Inoculation  of bacteriological and mycoplasma media  and of various 
tissue cultures excluded, beyond reasonable doubt, the presence of any known 
common agents  which might be causing hepatitis  in marmosets.  The use of 
control animals from the same colony and the blind passage of serums from such 
animals made it unlikely either that a naturally occurring marmoset agent was 
transmitted or that a dormant agent was activated by the experimental pro- 
cedures. However, these possibilities have not been completely eliminated. 
The disease demonstrated in marmosets was similar to hepatitis in man. Be- 
tween 50 and 100 % of animals in different experiments developed both signifi- 
cant elevations of SGOT and SICD activities and morphological changes in the 
liver but none of the animals became overtly sick. The results of other serum 
enzyme determinations also indicated that liver injury had occurred. Of particu- 
lar importance, elevation of the lactic dehydrogenase isoenzymes by electro- 
phoresis showed that only the fastest-moving fraction was elevated, and this 
isoenzyme is predominantly present in liver tissue.  1 Although serum bilirubin of 
marmosets, as in other nonhuman primates, is normally very low and is not a 
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bilirubinemia was observed in about 20 % of the positive animals. The biochemi- 
cal disease lasted from 1 to 12 wk and biphasic curves of serum enzymes were 
not infrequently observed. The morphologic alteration in the liver had many 
hallmarks of human viral hepatitis, particularly variations in the appearance of 
neighboring hepatocytes, acidophilic bodies, focal necrosis, portal inflammation 
with proliferation of bile ductules, and inflammatory reaction of the hepatic 
vein tributaries (18-20). However, the lesion was not identical with the picture 
typically seen in human viral hepatitis.  In a  patas monkey that developed 
hepatic disease after inoculation with icterogenic material, the histologic ap- 
pearance was also not identical with that in man with hepatitis (5). The char- 
acteristic lesion in marmosets differed from the occasional alterations found in 
control marmosets which were presumably the result of spontaneous infections, 
parasitism, or malnutrition. The first changes in liver biopsies were sometimes 
observed serveral days before significant serum enzyme rises could be measured 
and they frequently persisted for several weeks after the serum enzyme activi- 
ties had returned to normal. Morphological alterations were seen also in some 
inoculated animals which did not develop significant biochemical abnormalities. 
Some  animals used  in  these  studies are  being kept  for long-term follow-up 
studies in our laboratories, but it is not known yet whether they will develop 
recurrent attacks, active chronic hepatitis, or cirrhosis. 
No rise in antibodies to the agent has been demonstrated, the physical char- 
acteristics of the agent remain unknown, and it is yet to be proved that the 
agent inducing hepatitis in marmosets is indeed the agent of human viral hepati- 
tis by the reintroduction of the agent after several marmoset passages into man. 
Our case for considering that human viral hepatitis has been transmitted to 
marmosets rests on these results. All of the observations seem compatible with 
the assumption that the disease in marmosets is caused by "the" or one of the 
agents of human viral hepatitis and, if this assumption is correct, marmosets 
may then provide the long sought model system for the study of this disease. 
But before any assumption based on the findings reported in this publication 
can be regarded as more than a working hypothesis, the results with marmosets 
must be both confirmed and extended. 
It is unlikely that marmosets are  inherently more  susceptible  than  other 
nonhuman primates, and it is of interest to consider why they should appear so. 
Nonhuman primates which have been in captivity for some time before use often 
acquire immunity to human diseases by natural infection through contact with 
man, as occurred in measles studies with rhesus monkeys (21). Marmosets, by 
their ferocious character, minimise their contacts with man, and the time spent 
by marmosets in transit before arrival in the laboratory is usually shorter than 
for Mrican or Asian primates. Natural infections of marmosets with common 
human viruses, therefore, should be rare and this was shown in a previous study 
in which no antibodies to common human viruses could be demonstrated in 686  HEPATITIS  IN  MARMOSETS.  I 
marmosets which had been in our colony for 6 wk to 6 months (8). It is likely, 
therefore, that marmosets have no preexisting immunity to the agents of human 
viral hepatitis. In addition, it has been postulated that a predamaged liver is a 
prerequisite for the full  expression  of hepatitis.  Marmoset  livers  are  rarely 
completely normal,  due mainly to heavy parasitic infestations,  and this may 
predispose the animals to a fuller expression of the disease.  Future studies with 
parasite-free colony born animals may answer this question. 
SUMMARY 
Inoculation of human  serums or plasmas obtained during the early acute 
phase of viral  hepatitis  induced chemical and morphological hepatic disease  in 
marmosets in two out of  five  experimental series.  Thc discasc  was transmisslblc 
in series  from marmoset to marmoset with an apparent increased virulence of 
the causative agent in later  rearmost passages. The chemical evidence for the 
disease  was elevation  of  the activity  of SGOT  and SICD and of  serum bilirubin. 
In serial  liver  biopsy specimcns interpreted under code, a hcpatitis,  exhibiting 
some of the characteristics  of  human viral  hepatitis,  was readily  distinguishable 
from nonspecific changes. The morphological  changes preceded the biochem- 
ical alterations  and persisted  after  them. 
The data reported in these  studies  indicate  that marmosets may be susccpti- 
blc to human hcpatitis.  If these  observations are confirmed, these animals may 
provide good cxpcrimental models for  this  disease.  Final  proof that the hepatitis 
observed in marmosets  is caused by agents of human  viral  hepatitis is still 
lacking. 
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EXPLANATION  OF PLATES 
PLATE 81 
FIG. 1 a-1 e.  Livers of uninoculated marmosets. Hematoxylin and eosin. 
FIG. 1 a.  The liver cells have equal size and contain  finely vacuolated and granulated 
cytoplasm indicative of high glycogen content. In center is normal portal tract.  X 120. 
Fro. 1 b.  Note pigment granules around bile canaliculi and normal sinusoidal cells. 
X400. 
FIG.  1 c.  Note  thin wall of  central vein with flat endothelium. The  hepatocytes 
contain in  the  centrilobular zone  many pigment granules of  lipofuscin character. 
X400. 
FIG.  1 d.  Focal accumulation of sinusoidal cells,  some lymphocytes, no alteration 
of hepatocytes.  X 400. 
FIG. 1 e.  Slight excess of inflammatory cells in portal tract without proliferation of 
bile ductules. X  120. THE  ~OURNAL OF EXPERIMENTAL MEDICINE VOL. 125  PLATE  81 
(Deinhardt et al.: Hepatitis in marmosets) PLATE 82 
FIG. 2 a-2 d. Livers of inoculated marmosets. Hematoxylin and eosin. 
FIG. 2 a.  2 wk after inoculation before rise of enzyme activity (experiment  2-5). 
Variation in  size and  staining qualities of hepatocytes. Focal necrosis (arrow).  En- 
largement of portral tracts with conspicuous inflammatory reaction.  X  120. 
FIG. 2 b.  Same animal. Proliferation and activation of sinusoidal cells. X  400. 
FIG. 2 c.  On the peak of rise of enzyme activity (experiment 2-5, different animal). 
Variation in appearance of neighboring hepatocytes, some are dark (arrow) and others 
show  eosinophilie homogenization  (curved  arrow).  Note  dumping  of  chromatin  in 
nuclei and accumulation of inflammatory cells in sinusoids. X  240. 
FIG. 2 d.  Note severe portal inflammation with slight proliferation of bile ductules. 
Variation of hepatocytes with  accumulation of inflammatory cells within  sinusoids 
and  replacing liver cells. Activation of  endothelial lining in  central  vein  (arrow). 
X  120. (Same animal as Fig. 2 c.) THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  125  PLATE  82 
(Deinhardt et al.: Hepatitis in marmosets) PLATE 83 
FIG.  3 a-3f.  Livers  of  inoculated  marmosets  that  showed  elevated  activity  of 
serum enzymes. (All from experiment 2-5.) 
Fro. 3 s.  Variation in appearance of neighboring hepatocytes, both in cytoplasmic 
staining quality and in nuclei. Note eosinophilic homogenization (fine arrow) and focal 
necroses (heavy arrow). Hematoxylin and eosin.  X  240. 
FIG.  3 b.  Variation  in  glycogen content  of  neighboring hepatocytes.  PAS  stain. 
×  240. 
Fro.  3 c.  Ballooned  hepatocytes  with  central  nucleus  and  hydropic  cytoplasm 
(arrow)  and  focal  necroses  (inflammatory  cells  replace  liver  cell  which  had 
disappeared). Hematoxylin and eosin.  X  240. 
FIG.  3 d.  Irregular arrangement of nuclear chromatin producing stippling as well 
as central unstained zone (arrows). Hematoxylin and eosin.  X  400. 
FIG. 3 e.  Note thickening of central vein with accumulation of inflammatory cells 
in its wall and mobilization of sinusoidal cells. Hematoxylin and eosin.  ×  240. 
FIG. 3./.  Note variation in appearance of neighboring cells involving cytoplasm as 
well  as  nuclei.  Some  nuclei  are  ballooned.  In  some  hepatocytes  the  cytoplasm is 
irregularly clumped.  Inflammatory cells accumulate in  sinusoids  (arrow)  or  replace 
liver cells (curved arrow). Hematoxylin and eosin.  ×  400. THE  JOURNAL OF  EXPERIMEIWTAL MEDICINE  VOL.  125  PLATE  83 
(Deinhardt et al.: Hepatitis in marmosets) PLATE 84 
FIG. 4 a-4 e.  Livers of inoculated marmosets that exhibited rise in enzyme activi- 
ties. (Experiment 5-3.)  Hematoxylin and eosin. 
FIG. 4 a.  Proliferation of  sinusoidal cells throughout  with  focal accumulation  of 
inflammatory cells in dilated sinusoids. X  240. 
FIG.  4 b.  Severe  portal  inflammatory reaction with  accumulation  of  histiocytes, 
lymphocytes, and polymorphonuclear leukocytes. Note proliferation of bile ductules. 
X  240. 
FIG. 4 c.  Conspicuous variation in appearance of liver cells and foci of inflammatory 
cells in parenchyma. Extensive portal inflammation. X  60. 
FIG.  4 d.  Conspicuous  variations  of  liver  cells  throughout  involving  nuclei  and 
cytoplasm. Some cells lining the tissue spaces have a homogeneous eosinophilic cyto- 
plasm  resembling  acidophilic bodies  (arrow).  Inflammatory  cells  accumulate  and 
replace liver cells (curved arrow).  X  240. 
FI6. 4 e.  Small portal tract densely infiltrated by a  variety of inflammatory cells 
with conspicuous contribution of plasma cells (arrow).  X  400. THE JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  125  PLATE  84 
(Deinhardt et al.: Hepatitis in marmosets) PLATS 85 
Fro. 5 a-5 c.  Livers of inoculated marmosets. Hematoxylin and eosin. 
Fro. 5 a.  6-wk after inoculation and 2 wk after significant enzyme rise with normal 
enzyme activity at the time of examination. There is considerable variation in arrange- 
ment,  size and staining qualities of hepatocytes, focal necrosis and accumulation of 
sinusoidal cells. (Experiment 2-5.)  X  120. 
FIG. 5 b.  Same animal 2 wk later with continued normal enzyme activities. Note 
severe portal inflammatory reaction and parenchymal alteration.  X  120. 
FIG. 5 c.  Animal never developed elevated activities of enzymes. (Experiment 2-5.) 
Note accumulation of inflammatory cells in sinusoids (arrows) and slight disarray of 
liver cell plates. X  120. THE JOURNAL OF EXPERIMENTAL MEDICINE VOL.  125  PLATE 85 
(Deinhardt et al.: Hepatitis in marmosets) PLATE 86 
FIG.  6 a-6 d.  Serial  liver  biopsies  from  a  single  marmoset  in  experiment  2-5. 
Hematoxylin and eosin. 
FIG. 6 a.  15 days after inoculation and 1 day before first rise of enzyme activities. 
Note disarray of liver cell plates, focal necrosis,  excess of sinusoidal cells, and portal 
inflammatory reaction.  )<  120. 
FIG. 6 b.  6 wk after inoculation, when the rise of enzyme activities was returning to 
normal  levels.  Note  variation of  neighboring hepatocytes  with  many  dense  and 
ballooned cells,  portal  infiltration, and  inflammatory cells  in wall  of  central  vein 
(arrow).  X  120. 
FIG.  6 c.  8  wk  after  inoculation. Serum  enzyme activity has  remained  normal. 
Note  slight disarray of  liver cells,  focal  necroses  (arrow),  and portal inflammatory 
reaction. X  120. 
FIG. 6 d.  Focal necroses  near a  central vein (arrow)  the wall of which is normal. 
X 400. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  125  PLATE  86 
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